This inventor holds 5 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Hidenori Yano: Innovator in Biotechnology
Introduction
Hidenori Yano, based in Ota-ku, Japan, is a distinguished inventor known for his significant contributions to the field of biotechnology. With a portfolio of four patents, Yano has been instrumental in advancing research focused on therapeutic peptides.
Latest Patents
Yano's recent inventions include a unique conjugate comprising an active MMP-9-binding peptide. This inventive peptide features an amino acid sequence defined by SEQ ID NO: 18 and specifically binds to active proteases while avoiding pro-protease interactions. Another notable patent is the KLK5 inhibitory peptide, which consists of SPINK2 mutant peptide conjugates designed to inhibit KLK5. These conjugates are presented as Fc fusion peptides, where the Fc region can be the Fc region of human IgG1 or a fragment thereof. The sequence listings for the KLK5 inhibitory peptide conjugates include amino acids from SEQ ID NOs: 34, 36, 38, 40, 42, 44, 46, 48, 96, 50, 52, 54, 56, 58, or 60. Furthermore, Yano's work includes pharmaceutical compositions utilizing these conjugates aimed at treating KLK5-related diseases.
Career Highlights
Hidenori Yano is employed at Daiichi Sankyo Company, Limited, where he leverages his expertise in biotechnology to develop innovative solutions that address complex health issues. His contributions in the laboratory have made a significant impact on drug development and therapeutic research.
Collaborations
Throughout his career, Yano has collaborated with talented coworkers, including Daisuke Nishimiya and Shiho Ofuchi. Their collective efforts in research and development have contributed to the successful outcomes of their innovative projects.
Conclusion
With a strong commitment to advancing biotechnology, Hidenori Yano's patents highlight his role as an influential inventor. His work continues to pave the way for new treatments and therapeutic strategies, demonstrating the vital intersection of innovation and healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile